Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Working Memory01:24

Working Memory

387
Working memory refers to a combination of components, including short-term memory and attention, that allow an individual to hold information temporarily as we perform cognitive tasks. It is an essential cognitive function that enables the execution of complex tasks such as problem-solving, comprehension, and reasoning. Unlike short-term memory, which simply involves the storage of information for a brief period, working memory involves the active manipulation and processing of this...
387
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

163
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
163

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Movement Disorder Patients with Depression have Altered Corticostriatal Alpha-Beta Power Response to Reward and Loss.

eNeuro·2026
Same author

Position Statement of the American Society for Stereotactic and Functional Neurosurgery on Focused Ultrasound Lesioning of the Brain by Non-neurosurgeons.

Neurosurgery·2026
Same author

Charting Cervical Spinal Cord Morphometry Across the Lifespan.

bioRxiv : the preprint server for biology·2026
Same author

Molecular-Orientation Engineering Photonic Spin Textures Rotation in Organic Crystal Microcavities.

The journal of physical chemistry letters·2026
Same author

The dynamic functional connectivity peak index: Detection of interictal epileptic activity with fMRI.

Epilepsia·2026
Same author

Pediatric epilepsy surgery: Global survey of invasive explorations.

Epilepsia·2026

Related Experiment Video

Updated: Jul 25, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

401

Improving Visual Working Memory with Cholinergic Deep Brain Stimulation.

Janki M Bava1, Zhengyang Wang2, Sarah K Bick3

  • 1Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.

Brain Sciences
|June 28, 2023
PubMed
Summary
This summary is machine-generated.

Deep brain stimulation (DBS) of the nucleus basalis of Meynert shows promise for enhancing cognitive function, matching drug efficacy without loss over time. This suggests DBS could be a viable alternative treatment for cognitive impairments.

Keywords:
cholinergic activationdeep brain stimulationvisual working memory

More Related Videos

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum
11:47

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

28.8K
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
10:37

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

14.1K

Related Experiment Videos

Last Updated: Jul 25, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

401
Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum
11:47

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

28.8K
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
10:37

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

14.1K

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Neuromodulation

Background:

  • Acetylcholine is a key neurotransmitter for cognitive functions.
  • Cholinergic drugs enhance cognition but may have limitations.
  • Deep brain stimulation (DBS) is an emerging therapeutic modality.

Purpose of the Study:

  • To explore deep brain stimulation (DBS) as an alternative to pharmacological treatments for cognitive enhancement.
  • To investigate the efficacy of nucleus basalis of Meynert stimulation for cognitive improvement.

Main Methods:

  • Animal studies involving deep brain stimulation (DBS) of the nucleus basalis of Meynert.
  • Assessment of cognitive performance on visual working memory tasks.

Main Results:

  • DBS of the nucleus basalis of Meynert significantly improved cognitive performance.
  • The cognitive benefits of DBS were comparable to cholinesterase inhibitors.
  • DBS demonstrated sustained efficacy and a favorable safety profile in animal models.

Conclusions:

  • Deep brain stimulation (DBS) presents a promising therapeutic strategy for cognitive impairments.
  • DBS may offer a durable and safe alternative to current treatments for neurocognitive disorders like Alzheimer's disease.
  • Further human trials are warranted to evaluate DBS for treating cognitive decline.